• Je něco špatně v tomto záznamu ?

A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques

J. Bajgar, P. Hajek, JK. Zdarova, J. Kassa, A. Paseka, D. Slizova, O. Krs, K. Kuca, D. Jun, J. Fusek, L. Capek

. 2010 ; 25 (6) : 790-797.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026676

Tabun belongs to the most toxic nerve agents. Its mechanism of action is based on acetylcholinesterase (AChE) inhibition at the peripheral and central nervous systems. Therapeutic countermeasures comprise administration of atropine with cholinesterase reactivators able to reactivate the inhibited enzyme. Reactivation of AChE is determined mostly biochemically without specification of different brain structures. Histochemical determination allows a fine search for different structures but is performed mostly without quantitative evaluation. In rats intoxicated with tabun and treated with a combination of atropine and HI-6, obidoxime, or new oxime K048, AChE activities in different brain structures were determined using biochemical and quantitative histochemical methods. Inhibition of AChE following untreated tabun intoxication was different in the various brain structures, having the highest degree in the frontal cortex and reticular formation and lowest in the basal ganglia and substantia nigra. Treatment resulted in an increase of AChE activity detected by both methods. The highest increase was observed in the frontal cortex. This reactivation was increased in the order HI-6 < K048 < obidoxime; however, this order was not uniform for all brain parts studied. A correlation between AChE activity detected by histochemical and biochemical methods was demonstrated. The results suggest that for the mechanism of action of the nerve agent tabun, reactivation in various parts of the brain is not of the same physiological importance. AChE activity in the pontomedullar area and frontal cortex seems to be the most important for the therapeutic effect of the reactivators. HI-6 was not a good reactivator for the treatment of tabun intoxication.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026676
003      
CZ-PrNML
005      
20160307112132.0
007      
ta
008      
120816s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.3109/14756360903433373 $2 doi
035    __
$a (PubMed)21054236
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bajgar, Jiří, $d 1944- $7 js20020122033 $u Department of Toxicology, Faculty of Military Health Sciences, University of Defense, Trebesska, Hradec Kralove, Czech Republic. bajgar@pmfhk.cz
245    12
$a A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques / $c J. Bajgar, P. Hajek, JK. Zdarova, J. Kassa, A. Paseka, D. Slizova, O. Krs, K. Kuca, D. Jun, J. Fusek, L. Capek
520    9_
$a Tabun belongs to the most toxic nerve agents. Its mechanism of action is based on acetylcholinesterase (AChE) inhibition at the peripheral and central nervous systems. Therapeutic countermeasures comprise administration of atropine with cholinesterase reactivators able to reactivate the inhibited enzyme. Reactivation of AChE is determined mostly biochemically without specification of different brain structures. Histochemical determination allows a fine search for different structures but is performed mostly without quantitative evaluation. In rats intoxicated with tabun and treated with a combination of atropine and HI-6, obidoxime, or new oxime K048, AChE activities in different brain structures were determined using biochemical and quantitative histochemical methods. Inhibition of AChE following untreated tabun intoxication was different in the various brain structures, having the highest degree in the frontal cortex and reticular formation and lowest in the basal ganglia and substantia nigra. Treatment resulted in an increase of AChE activity detected by both methods. The highest increase was observed in the frontal cortex. This reactivation was increased in the order HI-6 < K048 < obidoxime; however, this order was not uniform for all brain parts studied. A correlation between AChE activity detected by histochemical and biochemical methods was demonstrated. The results suggest that for the mechanism of action of the nerve agent tabun, reactivation in various parts of the brain is not of the same physiological importance. AChE activity in the pontomedullar area and frontal cortex seems to be the most important for the therapeutic effect of the reactivators. HI-6 was not a good reactivator for the treatment of tabun intoxication.
650    _2
$a acetylcholinesterasa $x metabolismus $7 D000110
650    _2
$a zvířata $7 D000818
650    _2
$a atropin $7 D001285
650    _2
$a mozek $x účinky léků $x enzymologie $x patologie $7 D001921
650    _2
$a chemické bojové látky $x toxicita $7 D002619
650    _2
$a cholinesterasové inhibitory $x aplikace a dávkování $x toxicita $7 D002800
650    _2
$a reaktivátory cholinesterasy $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D002801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a čelní lalok $x účinky léků $x enzymologie $x patologie $7 D005625
650    _2
$a GPI-vázané proteiny $x metabolismus $7 D058851
650    _2
$a LD50 $7 D007928
650    _2
$a obidoxim chlorid $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D009768
650    _2
$a orgánová specificita $7 D009928
650    _2
$a oximy $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D010091
650    _2
$a organofosfáty $x aplikace a dávkování $x antagonisté a inhibitory $x toxicita $7 D010755
650    _2
$a pyridinové sloučeniny $x aplikace a dávkování $x farmakologie $x terapeutické užití $7 D011726
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a retikulární formace $x účinky léků $x enzymologie $x patologie $7 D012154
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hájek, Petr $7 xx0062490 $u Department of Anatomy, Medical Faculty of Charles University, Hradec Kralove, Czech Republic. hajekp@lfhk.uni.cz
700    1_
$a Žďárová Karasová, Jana, $d 1982- $7 xx0099787
700    1_
$a Kassa, Jiří, $d 1956- $7 mzk2003181395 $u Department of Toxicology, Faculty of Military Health Sciences, Hradec Kralove, Czech Republic. kassa@pmfhk.cz
700    1_
$a Paseka, Antonin
700    1_
$a Slížová, Dáša, $d 1953- $7 xx0019026 $u Department of Anatomy Medical Faculty Charles University, Hradec Králové
700    1_
$a Krs, Otakar $7 xx0104932 $u Department of Anatomy, Charles University in Prague, Faculty of Medicine, Hradec Kralove, Czech Republic
700    1_
$a Kuča, Kamil, $d 1978- $7 xx0041831 $u Purkyne Military Medical Academy, Department of Toxicology, PO Box 35/T, 500 01, Hradec Králové, Czech Republic
700    1_
$a Jun, Daniel, $d 1976- $7 xx0040498 $u Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic. jun@pmfhk.cz
700    1_
$a Fusek, Josef, $d 1945- $7 nlk20000076283 $u Military Medical Academy, Hradec Králové
700    1_
$a Čapek, Lukáš, $d 1979- $7 mzk2007390351 $u Department of Applied Mechanics, Technical University of Liberec, Studentska 2, 46117 Liberec, Czech Republic. lukas.capek@tul.cz
773    0_
$w MED00008009 $t Journal of enzyme inhibition and medicinal chemistry $x 1475-6374 $g Roč. 25, č. 6 (2010), s. 790-797
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21054236 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160307112149 $b ABA008
999    __
$a ok $b bmc $g 948718 $s 784022
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 25 $c 6 $d 790-797 $i 1475-6374 $m Journal of enzyme inhibition and medicinal chemistry $n J Enzyme Inhib Med Chem $x MED00008009
LZP    __
$b NLK122 $a Pubmed-20120816/11/01

Najít záznam

Citační ukazatele

Možnosti archivace